Skip to main content
    V

    VivoSim Labs, Inc. (VIVS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.12
    -0.00 (-2.68%)

    Market Cap: $2.58M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    83%(19/23)
    Avg Surprise
    +27.58%
    Streak
    6 Q

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin-10117.00%
    ROE-343.10%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio3.50xQuick Ratio3.49x
    Trading Statistics
    Beta1.56Avg Volume1.20M
    52-Week High$3.4052-Week Low$0.12

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 35.3% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 35.0, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$0.14
    SMA 20$0.15
    SMA 50$0.19
    SMA 200$0.97
    EMA 10$0.14
    EMA 20$0.15
    EMA 50$0.21
    EMA 200$0.83

    MACD

    Line: -0.02Signal: -0.02Hist: 0.00

    ADX

    ADX: 19.0+DI: 19.8-DI: 21.8

    Aroon & PSAR

    Aroon Up12.0
    Aroon Down100.0
    PSAR$0.18

    Bollinger Bands

    Upper Band$0.17
    Lower Band$0.12
    %B Position3591%(Upper)
    Band Width0.04

    RSI (14-Day)

    Neutral
    35.0

    Momentum Oscillators

    Stoch %K10.8
    Stoch %D22.5
    Williams %R-97.5
    ROC (10d)-19.3%
    Momentum-0.03
    CCI (20d)-178.8
    MFI (14d)65.9

    Volatility Measures

    ATR (14d)$0.02(15.2%)
    StdDev (20d)0.01
    Hist Vol120.3%(High)

    Volume Flow

    VWAP$0.13
    OBV186.0M
    AD Line-200.7M
    CMF (20d)-0.043

    Volume Metrics

    Avg Vol (20d)1.2M
    Vol Ratio0.2x(Low)
    VWMA (20d)$0.15

    Pivot Points

    R3$0.15
    R2$0.14
    R1$0.13
    Pivot Point$0.13
    S1$0.12
    S2$0.12
    S3$0.11

    Advanced Oscillators

    TSI-28.08
    Ultimate Osc37.4
    KST-246.02

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about VIVS

    VIVS Valuation

    VIVS Profitability: Margins, ROIC and FCF

    VivoSim Labs (VIVS) has a gross margin of 58.5%, an operating margin of -10117.0% and a net margin of 0.0%. It posts a -8245.2% FCF margin.

    Gross margin
    58.5%
    Operating margin
    -10117.0%
    Net margin
    0.0%
    ROE
    -343.1%
    FCF margin
    -8245.2%
    VIVS financial statements

    VivoSim Labs Competitors

    The companies most similar to VivoSim Labs (VIVS) include BioRestorative Therapies, Revelation Biosciences and Calidi Biotherapeutics.

    Sector: Healthcare

    Companies most similar to VivoSim Labs

    VIVS Bull Case vs Bear Case

    Bull case

    • VIVS beat EPS estimates in 87.5% of its last 8 reported quarters.

    Bear case

    • VIVS's quarterly revenue changed -51.4% year over year.

    VIVS Earnings: Beat Rate

    VivoSim Labs (VIVS) beat the EPS estimate in 7 of the 8 most recent quarters that had an estimate (87.5%).

    Beat rate
    7 of 8 quarters (87.5%)
    Average surprise
    50.8%
    VIVS earnings history

    Updated Nov 12, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About VIVS

    Does VIVS pay dividends?

    VivoSim Labs, Inc. (VIVS) does not currently pay a regular dividend.

    What is VIVS's market cap?

    VivoSim Labs, Inc. (VIVS) has a market capitalization of $2.58M with a current stock price of $0.12.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.